Official product information
Sciatica Pro Benefits: What Is Claimed, and What Is Evidenced
What the bottle front actually claims, what each of the ten ingredients is for according to its own federal fact sheet, and why none of that is a claim about sciatica.
Quick answer
The front of the bottle carries two claims and no more, Clinically Studied Ingredients and Supports Nerve Health, both structure/function claims with a dagger resolving to the FDA disclaimer. Four of the ten ingredients have a NIH fact sheet describing what that nutrient is for at a recommended intake; three carry trials run in diabetic neuropathy; three have no federal amount at all. None of it is a claim about sciatica, and this site makes none. 21 CFR 101.93 defines a disease as damage to an organ, part, structure or system of the body such that it does not function properly, and lists the name of the product as one of the ways a disease claim may be made.
2 claims on the front, both structure/function
The bottle front makes no claim about sciatica
Clinically studied ingredients, and supports nerve health. Everything stronger than that lives somewhere else.
Start with what the package actually says, because it is more restrained than the category it sits in. The front of this bottle carries no benefit claim about sciatica. It carries two structure/function claims and nothing else: “Clinically Studied Ingredients†” and “Supports Nerve Health†”. Both are daggered, and the dagger resolves on the back to the disclaimer in full.
The front of the bottle carries the wordmark Sciatica PRO +, the count and form, and exactly two claims, each one followed by a dagger: “Clinically Studied Ingredients†” and “Supports Nerve Health†”. Both are structure/function claims, both carry the dagger, and the dagger resolves to the disclaimer printed on the back. That is the careful way to do it, and it should be said before anything else about this label: the front does not say the product treats sciatica, eases sciatica or relieves sciatica. It says it supports nerve health, and it marks the sentence so a reader can find the disclaimer. The name on the same bottle is a different matter, and it has a page of its own.
So this page has two jobs and they are different in kind. The first is to say what each of the ten ingredients is for, according to its own federal fact sheet, in that fact sheet’s words. The second is to say — plainly, more than once, and without softening it — that none of that is a claim about sciatica.
01 The red flags, before the claims
When this stops being a shopping question
MedlinePlus’s own instruction, in its own words.
Some back and leg pain is not a shopping question. MedlinePlus Medical Encyclopedia, on sciatica, under When to Contact a Medical Professional, prints the instruction as “Contact your provider right away if you have:” and then lists nine symptoms. All nine are below, in MedlinePlus’s own words and in the order it prints them. If any of them describes you, stop reading this site and make the call. Nothing on this page is more important than that, and no supplement is.
- Unexplained fever with back pain
- Back pain after a severe blow or fall
- Redness or swelling on the back or spine
- Pain traveling down your legs below the knee
- Weakness or numbness in your buttocks, thigh, leg, or pelvis
- Burning with urination or blood in your urine
- Pain that is worse when you lie down, or awakens you at night
- Severe pain and you cannot get comfortable
- Loss of control of urine or stool (incontinence)
Those nine are the ones MedlinePlus puts under “Contact your provider right away if you have:” — they are printed here complete and unedited, because a shortened safety list is a worse thing than no safety list. The same page prints a second and slower list under “Also contact your provider if:”: you have been losing weight unintentionally; you use steroids or inject illicit drugs; you have had back pain before, but this episode is different and feels worse; and this episode of back pain has lasted longer than 4 weeks. Those four are reasons to be seen rather than reasons to go now, and the distinction between the two lists is MedlinePlus’s own rather than this desk’s.
This matters more on a site about this product than it would on almost any other. A capsule bought online is a thing you can start taking tonight without telling anybody, and the one cost of that is the weeks it can absorb while a symptom that needed a clinician goes unreported. If you have any of the symptoms above, the correct next step is a provider, today, not a purchase.
A page about what a product is for is exactly the page that list belongs on. If any line in it describes you, the question is not which pack size to buy.
4 of 10 rows with a federal fact sheet to quote
What each ingredient is for, in its own fact sheet’s words
Four fact sheets, three trials, three rows with neither — and not a sentence about sciatica in any of them.
Here is the first job done: all ten rows, with what each one is for according to the federal fact sheet that covers it, quoted rather than characterised. Four rows have such a fact sheet. Six do not, and that is what their cell says.
| Row | Printed amount | What the federal record says it is for | And the limit the same source puts on it |
|---|---|---|---|
| Vitamin D3 (as Cholecalciferol) | 20 mcg | Bone and general health at the recommended intake. ODS gives an RDA of “15 mcg (600 IU)” for adults 19 to 70 and “20 mcg (800 IU)” for 71 and over. | ODS does not say vitamin D supplements help pain. On multiple sclerosis, a disease of the nerves: “taking vitamin D supplements does not keep symptoms from getting worse or coming back.” |
| Vitamin B6 (as Pyridoxine hydrochloride) | 1.7 mg | Normal nerve function at the recommended intake. The RDA is 1.3 mg for adults 19 to 50 and 1.7 mg for men 51 and over. | The direction of the risk is the other way: “taking high amounts of vitamin B6 from supplements for a year or longer can cause severe nerve damage”. At 1.7 mg this label is restrained, and that is a credit. |
| Folate | 383 mcg DFE | Cell division and red blood cell formation at the recommended intake of “400 mcg DFE” for adults. | The nerve-relevant sentence is a caution, not a benefit: “Taking large amounts of folate supplements might hide a vitamin B12 deficiency because these supplements can correct the anemia that the vitamin B12 deficiency causes but not the nerve damage”. This row is well under the “1,000 mcg” upper limit. |
| Vitamin B12 (as Methylcobalamin) | 2 mcg | Nerve and blood cell health at the RDA of “2.4 mcg” for adults. ODS: “Vitamin B12 deficiency can damage the nervous system even in people who don’t have megaloblastic anemia.” | And the limit on that, from the same fact sheet, on energy: “vitamin B12 doesn’t provide these benefits in people who get enough B12 from their diet.” |
| Alpha Lipoic Acid | 400 mg | No federal consumer fact sheet was supplied for this ingredient, so this site publishes no federal purpose for it. | What exists is the trial: SYDNEY 2, in diabetic distal symmetric polyneuropathy. “An oral dose of 600 mg once daily appears to provide the optimum risk-to-benefit ratio.” |
| Benfotiamine | 150 mg | No federal consumer fact sheet was supplied for this ingredient. | The trial, in symmetrical distal diabetic polyneuropathy: “Benfotiamine may extend the treatment option for patients with diabetic polyneuropathy.” |
| Acetyl L-Carnitine | 50 mg | No federal consumer fact sheet was supplied for this ingredient. | The Cochrane review, in diabetic peripheral neuropathy: “We are uncertain whether ALC reduces pain in DPN, as the evidence is sparse and of very low certainty.” |
| Ashwagandha Powder (Root) | 25 mg | No federal consumer page supplied to this desk gives an amount for this ingredient for nerve pain. | Present, printed and small. No effect is assigned to it here. |
| Broccoli Powder (Brassica Oleracea)(leaf) | 25 mg | No federal consumer page supplied to this desk gives an amount for this ingredient for nerve pain. | Present, printed and small. No effect is assigned to it here. |
| Turmeric Powder (Root) | 25 mg | No federal consumer page supplied to this desk gives an amount for this ingredient for nerve pain. | Present, printed and small. No effect is assigned to it here. |
Four of the ten rows have a NIH Office of Dietary Supplements consumer fact sheet. None of those fact sheets is about sciatica, and none of them says a supplement of that vitamin relieves pain.
Now the second job, and it is the whole reason this page exists. Nothing in that table is a claim about sciatica. Every purpose in the third column is a purpose a vitamin has in a diet — nerve and blood cell health at the recommended intake, cell division, bone health. Every trial in the fourth column was run in diabetic neuropathy. Not one line of it is evidence that this product does anything for a compressed sciatic nerve, and this site does not present it as such. The condition this product is named after appears in no cell of that table.
4 phrases, turned over
Each phrase, against what the record says
Where the words come from, and what the federal record puts beside them.
Four cards. Each front is where a word comes from — the bottle, the category or the name — and each back is what the federal record publishes about it. Two statements printed next to each other is the whole of what this site can honestly do here.
printed on the front
Supports nerve health
One of the two claims on the bottle front, with a dagger: a structure/function claim, not a claim about a disease, and the dagger resolves to the FDA disclaimer on the back.
Tap to turnon the federal record
Supports nerve health
NIH ODS gives the clearest federal reason a nerve formula carries B12: “Vitamin B12 deficiency can damage the nervous system even in people who don’t have megaloblastic anemia.” That is a sentence about deficiency. It is not a sentence about supplementing when your B12 is already adequate, and ODS says so in the next breath.
Tap to turn backprinted on the front
Clinically studied ingredients
The other front-of-bottle claim, and the only one on this product a reader can audit. It says studied. It does not say studied in sciatica.
Tap to turnon the federal record
Clinically studied ingredients
True of three rows out of ten: alpha lipoic acid, benfotiamine and acetyl L-carnitine. Every one of those trials was run in diabetic neuropathy, and this label prints two thirds, one half and one thirtieth of the doses they used.
Tap to turn backon the sales page, not the bottle
Nerve pain
The product is sold into a category defined by nerve pain. The bottle front makes no claim about pain at all, and there is no analgesic of any kind in the capsules.
Tap to turnon the federal record
Nerve pain
NINDS: “Examples of conditions that cause neuropathic pain are diabetic neuropathy, shingles, and sciatica.” Two different conditions in one sentence. Every trial behind this label was run in the first one.
Tap to turn backthe name on the bottle
Sciatica
Not a claim printed on the front at all — it is the product’s name. 21 CFR 101.93(g)(2)(iv)(A) lists “The name of the product;” as one of the ways a claim about a disease may be made.
Tap to turnon the federal record
Sciatica
MedlinePlus: “Sciatica occurs when there is pressure on or damage to the sciatic nerve.” The regulation and the name are set beside each other on this page and this desk stops there. No finding about this product has been made by FDA or by anybody here.
Tap to turn backRead the four backs in a row and the pattern is consistent. Where a federal page exists it describes a nutrient doing a nutrient’s job at a recommended intake, or it publishes a caution. Where a trial exists it was run in a different condition at a larger amount. And where the strongest word of all appears — the condition itself — it is not a claim on the label at all. It is the name on the front.
02 21 CFR 101.93, and the name on the bottle
The regulation, the name, and a full stop
State the regulation. State the name. Draw no conclusion on the reader’s behalf.
Everything above has been about the two daggered claims on the front, and both of them are carefully made. One phrase on the same bottle was not written by a compliance department at all, and it is the biggest type on the package.
And then there is the name. 21 CFR 101.93 defines a disease as “damage to an organ, part, structure, or system of the body such that it does not function properly.” The same section, at (g)(2)(iv)(A), lists one of the ways a claim about a disease may be made: “The name of the product;” MedlinePlus, on the condition: “Sciatica occurs when there is pressure on or damage to the sciatic nerve.” The product is called Sciatica Pro. Those three things are set beside each other here and this site stops there. This desk does not write that the product is illegal, mislabelled or in violation of anything. FDA has made no finding about this product and neither has this desk; no enforcement action, warning letter or determination was supplied, and none is implied. What can be said is the shape of it: the same bottle carries a carefully constructed structure/function claim with the correct disclaimer and a product name that is the name of a condition.
The regulation and the name are now on the same page, and this desk stops writing at that full stop. What a reader does with the two of them is a reader’s business.
1 disclaimer, printed in the correct words
What the structure/function construction cannot do
Keeping a claim on the right surface is a compliance decision. It is not an evidence one.
What the construction cannot do is make a claim true. FDA does not review a structure/function claim before it is used — the required disclaimer, at 21 CFR 101.93(c)(1), says so in its own words: “This statement has not been evaluated by the Food and Drug Administration.” and “This product is not intended to diagnose, treat, cure, or prevent any disease.” The one front-of-bottle claim a reader can actually audit is the other one, and this site audits it: “Clinically Studied Ingredients†” is true of three of the ten rows — alpha lipoic acid, benfotiamine and acetyl L-carnitine — and every one of those trials was in diabetic neuropathy, at a larger amount than this label prints. The claim says studied. It does not say studied in sciatica, and it would not be true if it did.
Three things the construction cannot do, stated plainly. It cannot make a claim true: the required disclaimer says in its own words that “This statement has not been evaluated by the Food and Drug Administration.” It cannot substitute for evidence about the finished product: no trial of this formula was supplied to this desk, so the claims rest on single-ingredient literature at amounts this panel does not reach. And it cannot reach across to the condition on the front, because the second half of the same disclaimer is explicit: “This product is not intended to diagnose, treat, cure, or prevent any disease.”
One more sentence belongs here and it is the one most often misread on sites in this category. No dietary supplement is approved by FDA before it is sold, and a facility registration is a filing rather than an approval. Nothing on this site should be read as FDA having approved, cleared, reviewed or verified this product, these claims or these ten printed amounts.
10 printed amounts, and three studied ones to compare them to
The fair summary, in both directions
A careful label on a product whose evidence was gathered in another condition is still a careful label.
So what is a buyer left holding? A careful label, a real but misaddressed evidence base, and a name that does work the front of the bottle refuses to do.
In the product’s favour, and it is a real list. Ten rows and a printed amount on every one, with no proprietary blend anywhere on the panel. All four percentages arithmetically correct, including a folate row that needed a two-unit conversion first. Vitamin B6 held at 1.7 mg on a nerve product, when the federal upper intake level sits fifty times higher. Three of the ten rows carrying genuinely named, published trials. A caution paragraph that names four groups and tells them to ask a physician first. A full storage and tamper line. The FDA disclaimer in the correct words. A hypromellose capsule, printed as a vegetable capsule. And two front-of-bottle claims that are both structure/function claims, both daggered.
Against it. Seven of the ten rows have no studied amount to be compared with at all. The three that do print two thirds, one half and one thirtieth of the doses their trials used, and every one of those trials was carried out in diabetic neuropathy rather than in sciatica. No trial of the finished formula was supplied. Two different companies appear on one product with two different phone numbers and nothing to explain the relationship. The marketing roundels include a doctor formulated mark that names nobody. And the price, the shipping figure and the length of the guarantee were not supplied to this desk at all, because the pack says “Print live checkout prices. Do not guess.” So this site prints none of them: the figure for one, three or six bottles, the shipping line and the length of the window are all shown at the checkout, and the sentence a reader needs from this page is to read them there, before paying, and screenshot the page with the date showing.
This desk does not call this product a scam and will not. The label is careful and in several respects better than most of what has crossed this desk. The findings here are about quantity, about the condition the trials were run in, and about the name.
What would move this page
Evidence about this formula, at these amounts, in this dose form, in people with sciatica, published where a reader can check it. Until that exists, the most useful question is not whether to buy it but whether anything above is a reason for you in particular not to — and if what prompted the search was a symptom that is new, severe or getting worse, the list at the top of this page is the part that matters.
Questions
Sciatica Pro FAQ: benefits questions
What does “Clinically Studied Ingredients” mean on the bottle?
It is the one front-of-bottle claim you can audit, so here is the audit. Three of the ten ingredients carry named clinical trials: alpha lipoic acid, benfotiamine and acetyl L-carnitine. Every one of those trials was in diabetic neuropathy, and every one used more than this label prints. The claim says studied. It does not say studied in sciatica.
Does Sciatica Pro cure sciatica?
This bottle does not claim to, and the disclaimer printed on it says so in the regulator’s own words: “THIS PRODUCT IS NOT INTENDED TO DIAGNOSE, TREAT, CURE OR PREVENT ANY DISEASE.” No trial cited anywhere on this site was carried out in sciatica, so nothing published supports a claim of that kind either. MedlinePlus, separately, notes that “Sometimes sciatica goes away on its own.”
Will the vitamins in it do anything for my sciatica?
Nothing federal says so. ODS explains why B12 belongs in a nerve conversation at all — “Vitamin B12 deficiency can damage the nervous system even in people who don’t have megaloblastic anemia” — which is a statement about deficiency. On vitamin D and a nerve disease, ODS says that in multiple sclerosis “taking vitamin D supplements does not keep symptoms from getting worse or coming back.”
Is Sciatica Pro FDA approved?
No, and no dietary supplement is. FDA does not approve dietary supplements before they are marketed. The disclaimer printed on this bottle says the same thing in its own words: “THESE STATEMENTS HAVE NOT BEEN EVALUATED BY THE FOOD & DRUG ADMINISTRATION.”
When should I stop taking it and call someone?
MedlinePlus Medical Encyclopedia prints the instruction as “Contact your provider right away if you have:” and the list includes “Loss of control of urine or stool (incontinence)”, fever with back pain, and weakness or numbness in the leg or pelvis. If any of those describes you, make the call today.
Is there a money-back guarantee if it does not work?
No guarantee length or conditions were supplied to this desk. The pack says only “Guarantee: As printed on the live checkout”, which is where the length and the conditions are printed. Read the real wording at the checkout before you pay, and screenshot it with the date showing. A money-back roundel was supplied as an image; an image is not a term.
References
Sources for this page
- Electronic Code of Federal Regulations. 21 CFR 101.93 — Certain types of statements for dietary supplements. www.ecfr.gov. Accessed October 11, 2026.
- U.S. Food and Drug Administration. Structure/Function Claims. www.fda.gov. Accessed October 11, 2026.
- NIH Office of Dietary Supplements. Vitamin D — Consumer. ods.od.nih.gov. Accessed October 11, 2026.
- NIH Office of Dietary Supplements. Vitamin B6 — Consumer. ods.od.nih.gov. Accessed October 11, 2026.
- NIH Office of Dietary Supplements. Folate — Consumer. ods.od.nih.gov. Accessed October 11, 2026.
- NIH Office of Dietary Supplements. Vitamin B12 — Consumer. ods.od.nih.gov. Accessed October 11, 2026.
- MedlinePlus Medical Encyclopedia, U.S. National Library of Medicine. Sciatica (Medical Encyclopedia). medlineplus.gov. Accessed October 11, 2026.
- U.S. Food and Drug Administration. Health Fraud Scams. www.fda.gov. Accessed October 11, 2026.
Next
Keep reading
The condition nobody studied
Diabetic neuropathy, sciatica, and the gap this site leaves standing.
Read itThe ten amounts, against what was studied
Two thirds, one half and one thirtieth, with the shortfall drawn.
Read itWho it is for, and who should ask first
The four groups the label’s own caution tells to see a physician.
Read itOrder Sciatica Pro from the official page
60 capsules a bottle, two a day, thirty days a bottle. Ten ingredients, ten printed amounts, no proprietary blend, and about 677 mg of declared actives a serving. Price and guarantee are read from the live checkout. Order support +1 (302) 200-3480.
Price and guarantee are read on the checkout page — screenshot it with the date before you pay · ships from inside the US · order support +1 (302) 200-3480